High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Blood cancer journal - 12(2022), 9 vom: 05. Sept., Seite 128 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khwaja, Jahanzaib [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
69G8BD63PP |
|---|
| Anmerkungen: |
Date Completed 08.09.2022 Date Revised 19.09.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41408-022-00717-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34581715X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34581715X | ||
| 003 | DE-627 | ||
| 005 | 20231226025933.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41408-022-00717-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM34581715X | ||
| 035 | |a (NLM)36064540 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khwaja, Jahanzaib |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2022 | ||
| 500 | |a Date Revised 19.09.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Bortezomib |2 NLM | |
| 650 | 7 | |a 69G8BD63PP |2 NLM | |
| 650 | 7 | |a belantamab mafodotin |2 NLM | |
| 650 | 7 | |a DB1041CXDG |2 NLM | |
| 700 | 1 | |a Bomsztyk, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmood, Shameem |e verfasserin |4 aut | |
| 700 | 1 | |a Wisniowski, Brendan |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Raakhee |e verfasserin |4 aut | |
| 700 | 1 | |a Tailor, Anish |e verfasserin |4 aut | |
| 700 | 1 | |a Yong, Kwee |e verfasserin |4 aut | |
| 700 | 1 | |a Popat, Rakesh |e verfasserin |4 aut | |
| 700 | 1 | |a Rabin, Neil |e verfasserin |4 aut | |
| 700 | 1 | |a Kyriakou, Charalampia |e verfasserin |4 aut | |
| 700 | 1 | |a Sive, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Esposti, Simona Degli |e verfasserin |4 aut | |
| 700 | 1 | |a Larkin, Daniel F P |e verfasserin |4 aut | |
| 700 | 1 | |a Worthington, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Hart, Alyse |e verfasserin |4 aut | |
| 700 | 1 | |a Dowling, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Correia, Nuno |e verfasserin |4 aut | |
| 700 | 1 | |a Bygrave, Ceri |e verfasserin |4 aut | |
| 700 | 1 | |a Rydzewski, Andrzej |e verfasserin |4 aut | |
| 700 | 1 | |a Jamroziak, Krzysztof |e verfasserin |4 aut | |
| 700 | 1 | |a Wechalekar, Ashutosh D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood cancer journal |d 2011 |g 12(2022), 9 vom: 05. Sept., Seite 128 |w (DE-627)NLM219701628 |x 2044-5385 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:9 |g day:05 |g month:09 |g pages:128 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41408-022-00717-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2022 |e 9 |b 05 |c 09 |h 128 | ||